Thrombin-stimulated platelet aggregation is inhibited by kallikrein in a time- and concentration-dependent manner

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 63, Issue 4, 2003, Pages 279-286

  Veloso, D ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

ADP; Plasma; Prekallikrein; Washed human platelets

Indexed keywords

ADENOSINE DIPHOSPHATE; FIBRINOGEN; KALLIKREIN; PREKALLIKREIN; THROMBIN;

ARTICLE; BLEEDING; BLOOD CLOTTING; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG INHIBITION; HEART INFARCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS;

EID: 0042232476     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510310001735     Document Type: Article

References (31)

1. Mandle RJ Jr, Kaplan AP. Human plasma prekallikrein. Mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis. J Biol Chem 1977; 252: 6097-104.
2. Griffin JH, Cochrane CG. Recent advances in the understanding of contact activation reactions. Semin Thromb Hemostasis 1979; 5: 254-73.
3. Veloso D, Silver LD, Hahn S, Colman RW. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface. Blood 1987; 70: 1053-62.
4. McMullen BA, Fujikawa K, Davie EW. Location of the disulfide bonds in human plasma prekallikrein: the presence of four novel apple domains in the amino-terminal portion of the molecule. Biochemistry 1991; 26: 2050-6.
5. Colman RW. Surface-mediated defense reactions. The plasma contact activation system. J Clin Invest 1984; 73: 1249-53.
6. Kaplan AP, Silverberg M. The coagulation-kinin pathway of human blood. Blood 1987; 70: 1-15.
7. Currimbhoy Z, Vinciguerra V, Palakavongs P, Kuslansky P, Degnan TJ. Fletcher factor deficiency and myocardial infarction. Am J Clin Pathol 1976; 65: 970-4.
8. Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore) 1983; 62: 248-55.
9. Harris MG, Exner T, Richard KA, Kronenberg H. Multiple cerebral thrombosis in Fletcher factor (prekallikrein) deficiency: a case report. Am J Hematol 1985; 19: 387-93.
10. Davey M, Luscher E. Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets. Nature 1967; 216: 857-8.
11. Cassaro CMF, Sampaio MU, Maeda NY, Chamone DF, Sampaio CAM. Human plasma kallikrein: effect on the induced platelet aggregation. Thromb Res 1987; 48: 81-7.
12. Veloso D, Colman RW. Western blot analyses of prekallikrein and its activation products in human plasma. Thromb Haemost 1991; 65: 382-8.
13. Briseid K, Johannesen S. Part of purified human plasma kallikrein removed together with a remaining IgG fraction: immunoblot experiments and functional tests. Scand J Clin Lab Invest 2002; 62: 21-4.
14. Veloso D, Schilling J, Shine JD, Fitch WM, Colman RW. Recent evolutionary divergence of plasma prekallikrein and factor XI. Thromb Res 1986; 43: 153-60.
15. Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol 1972; 22: 193-204.
16. Veloso D, Smith JI, Denny S, Cosgriff TM. Structure, kinetics and function of human and rhesus plasma prekallikreins are similar. Thromb Haemost 1992; 68: 526-33.
17. Vu T-KH, Hung DT, Wheaton VI, Goughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
18. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV, Tam C, Coughlin SR. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-4.
19. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999; 103: 879-87.
20. Xu W-F, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW, Foster DC. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci 1998; 95: 6642-6.
21. Covic L, Gresser AL, Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 2000; 39: 5458-67.
22. Molino M, Bainton DF, Hoxie JA, Coughlin SR, Brass LF. Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation. J Biol Chem 1997; 272: 6011-7.
23. Daniel JL, Dangelmaier C, Jin J, Kim YB, Kunapuli SP. Role of intracellular signaling events in ADP-induced platelet aggregation. Thromb Haemost 1999; 82: 1322-6.
24. Kuliopulos A, Covic L, Seeley SK, Sheridan PJ, Helin J, Costello C. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 1999; 38: 4572-85.
25. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998; 95: 8070-4.
26. Brass LF. More pieces of the platelet activation puzzle slide into place. J Clin Invest 1999; 104: 1663-5.
27. Ruggeri ZM. Old concepts and new developments in the study of platelet aggregation. J Clin Invest 2000; 105: 699-701.
28. Wang R, Shattil SJ, Ambruso DR, Newman PJ. Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(Ib)-beta3 complex. J Clin Invest 1997; 100: 2393-403.
29. Suidan HS, Clemetson KJ, Brown-Luedi M, Niclou SP, Clemetson JM, Tschopp J, Monard D. The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin. Biochem J 1996; 315: 939-45.
30. Kleniewski J, Donaldson VH, Wagner CJ. Some molecular and functional changes in high molecular weight kininogen induced by plasmin and trypsin. Thromb Res 1982; 25: 387-99.
31. Veloso D, Tseng SY, Craig AR, Colman RW. Binding of a monoclonal anti-human plasma prekallikrein antibody to the complexes of kallikrein with Cl-inhibitor and alpha 2-macroglobulin analyzed by immunoblot and "sandwich" assays. Adv Exp Med Biol 1989; 247A: 499-505.